Copaiba: Silver bullet or snake oil?

Sales of the essential oil copaiba [koh-pey-buh] are increasing, at least in part, because more than 54 million Americans suffer from arthritis. The traditional way to treat arthritis is using NSAIDs and COXIBs, which are not without adverse events. For arthritis sufferers, copaiba may turn out to be a silver bullet or, perhaps, snake oil.

Stem cells edited to fight arthritis

Using CRISPR technology, a team of researchers rewired stem cells’ genetic circuits to produce an anti-inflammatory arthritis drug when the cells encounter inflammation. The technique eventually could act as a vaccine for arthritis and other chronic conditions.

Helping juvenile idiopathic arthritis sufferers

A drug combination that could help thousands of children with arthritis has been discovered by a team of researchers. Children and adolescents with Juvenile Idiopathic Arthritis (JIA) are likely to develop uveitis, a condition that causes inflammation in the middle layer of the eye. The drug combination discovery will help preventing them from serious complications, including blindness.

Immune suppressant ineffective in treating leprosy inflammation

Throughout the course of a leprosy infection, patients often have episodes of painful inflammation affecting their skin and nerves. Researchers have continuously struggled with finding effective drugs to treat these so-called ‘type 1 reactions,’ and now one more study has come up empty-handed. The immune-suppressant azathioprine did not improve the standard of care treatment with steroids, researchers report.